A randomized, placebo-controlled, parallel-group, double-blind, multicenter, 7-month study of omalizumab, in patients with severe allergic asthma on daily treatment with inhaled corticosteroids.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2015
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.